Oteracil、ts1藥物、ts-1仿單在PTT/mobile01評價與討論,在ptt社群跟網路上大家這樣說
Oteracil關鍵字相關的推薦文章
Oteracil在【藥學教育】TS-1(S-1)在胃癌的作用機制與使用TS-1(S-1) in ...的討論與評價
TS-1為一種新型口服5-FU的複方化療藥物,其中包含三種不同藥理作用的藥品:tegafur、gimeracil與oteracil,它們分別以莫耳數比1:0.4:1組合而成。
Oteracil在【篤實關懷倫理卓越】光田綜合醫院Kuang Tien General Hospital的討論與評價
... (依診斷事審), 藥品許可證, 衛署藥輸字第025243號. 中文名, 愛斯萬膠囊20毫克, 健保局藥理類別, 100000 抗癌藥物. 學名, Gimeracil+Oteracil+Tegafur, 外觀描述 ...
Oteracil在Tegafur, Gimeracil, Oteracil Potassium的討論與評價
Tegafur, Gimeracil, Oteracil Potassium. 【OTS】TS-1(TS-1® ) Capsules 20mg. ATC Code:L01BC53. 【OTS1】(專案)TS-1(TS-1® ) Capsules 20mg. ATC Code:L01BC53.
Oteracil在ptt上的文章推薦目錄
Oteracil在用藥指導 - 國軍高雄總醫院的討論與評價
Tegafur,gimeracil,oteracil potassium. 廠牌. 臺灣東洋. 院內碼. OTS1. 健保碼. BC25243100. 分類. 抗癌藥物. ATC CODE. L01BC53.
Oteracil在Tegafur/gimeracil/oteracil - Wikipedia的討論與評價
Tegafur/gimeracil/oteracil (Teysuno) was approved for medical use in the European Union in March 2011. ... It has not been approved by the U.S. Food and Drug ...
Oteracil在GIMERACIL的用法與用量、成分、適應症、副作用|藥典的討論與評價
胃癌用藥。 胃癌用藥。 ... 本藥會和化療藥物5-FU併用,選擇性可逆抑制存在於肝臟的5-FU分解代謝酶-DPD,而提高體內5-FU的濃度,進而增強抗腫瘤療效。 和化療藥物5-FU併用, ...
Oteracil在Tegafur/gimeracil/oteracil (S-1) approved for the ... - PubMed的討論與評價
由 M Kobayakawa 著作 · 2011 · 被引用 62 次 — S-1 is a combination of three pharmacological compounds, namely tegafur, gimeracil, and oteracil potassium. Tegafur is a prodrug of 5-fluorouracil (5-FU), an ...
Oteracil在Assessment Report For Teysuno (tegafur/gimeracil/oteracil ...的討論與評價
2010年12月16日 — Teysuno contains three active substances, tegafur, gimeracil and oteracil; oteracil in the form of potassium salt).
Oteracil在Gimeracil: Uses, Interactions, Mechanism of Action - DrugBank的討論與評價
Gimeracil is a DPD inhibitor used as an adjunct to antineoplastic therapy to increase the systemic concentrations and therapeutic ...
Oteracil在Definition of tegafur-gimeracil-oteracil potassium - NCI Drug ...的討論與評價
tegafur-gimeracil-oteracil potassium ... An orally bioavailable fluoropyrimidine antagonist composed of tegafur combined with two modulators of 5-flurouracil (5- ...